Loading...

Loading...

Adjust height of sidebar

KMap

People

Adjust height of sidebar

KMap

Profile

Picture of Benjamin Lee

Benjamin Lee

Professor, Urology | Department Chair, Urology | Director, GU Cancer - Disease Oriented Strategic Planning Team | Member of the Graduate Faculty

College of Medicine - Tucson

Collaboration(40)

Andrew Rouse
Anne Cress
Megha Padi
Patrick Wightman
Ritu Pandey

Page 1 of 8

Grants(7)

Targeting Lysosomal Vulnerabilities in Renal Pathogenesis
Active·2022·$14.1K / $1.4M·
External
Co-Investigator (COI)
lysosomes, renal disease, pathogenesis, therapeutics, drug discovery
Bioengineered Prostate-on Chip: Mechanisms of Stromal Dysregulation in Prostate Cancer
Active·2021·$93.8K / $1.9M·
External
Co-Investigator (COI)
cancer, bioengineering, prostate, mechanisms, stromal dysregulation
Abdominal Adiposity in Early-Onset and Aggressive Clear Cell Renal Cell Carcinoma and Health Disparities
Active·2021·$43.3K / $865.5K·
External
Co-Investigator (COI)
cancer, obesity, health disparities, renal cell carcinoma, adiposity
A Mixed Method to Identify Causes of Kidney Cancer Surgical Disparities in Arizona
2020·$19.4K / $388.5K·
External
Co-Investigator (COI)
cancer, surgery, disparities, mixed methods, kidney
A Multi-Center, Randomized, Assessor-Blind, Controlled Trial Comparing the Occurrence Of Major Adverse Cardiovascular Events (MACEs) in Patients with Prostate Cancer And Cardiovascular Disease...
2019·$238.9K·
External
Principal Investigator (PI)
oncology, cardiovascular, clinical trial, cancer, randomized trial

Page 1 of 2

Publications(69)

Recent

Neighborhood social vulnerability and disparities in time to kidney cancer surgical treatment and survival in Arizona

2024

social vulnerability, health disparities, kidney cancer, surgical treatment, survival

AR loss in prostate cancer stroma mediated by NF-κB and p38-MAPK signaling disrupts stromal morphogen production.

2024

prostate cancer, stromal morphogen production, nf-κb signaling, p38-mapk signaling, ar loss

Tuberous Sclerosis Complex TSC) Identified by Genetic Testing After Histologic Diagnosis of Chromophobe Renal Cell Carcinoma

2024

genetic testing, renal cell carcinoma, tuberous sclerosis complex, histologic diagnosis, genetic identification

Clear cell renal cell carcinoma molecular variations in non-Hispanic White and Hispanic patients

2023

cancer, ethnicity, molecular biology, genetics, health disparities

Digital Image analysis using Video microscopy of human-derived prostate cancer vs normaprostate organoids to assess migratory behavior on extracellular matrix proteins.

2023

digital image analysis, video microscopy, prostate cancer, organoid research, extracellular matrix

Targeting NEDDylation is a Novel Strategy to Attenuate Cisplatin-induced Nephrotoxicity

2023

neddylation, cisplatin, nephrotoxicity, targeted therapy, drug-induced toxicity

Gemcitabine as first-line therapy for high-grade non-muscle invasive bladder cancer: results from a tertiary center in the contemporary BCG-shortage era

2023

bladder cancer, chemotherapy, drug shortage, treatment

A Typical Progression Pattern after Pre-Docetaxel Abiraterone for Metastatic Prostate Cancer: Report of Two Cases

2022

prostate cancer, metastatic, abiraterone, progression pattern, pre-docetaxel

Impacts of Neighborhood Characteristics and Surgical Treatment Disparities on Overall Mortality in Stage I Renal Cell Carcinoma Patients

2022

neighborhood characteristics, surgical treatment disparities, overall mortality, stage i renal cell carcinoma, impacts

Renal Cell Carcinoma Surgical Treatment Disparities in American Indian/Alaska Natives and Hispanic Americans in Arizona

2022

cancer, healthcare disparities, surgical treatment, ethnic disparities, native american health